|
Index of reports
> Cases with Thrombocytopenia (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-20
Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Ifosfamide
Start date: 2012-05-17
End date: 2012-05-18
Mesna
Start date: 2012-05-17
End date: 2012-05-18
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-06
Patient: 49 year old female
Reactions: Erythema Infectiosum, Hepatitis Acute, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Epirubicin
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Vincristine Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Lamivudine
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-03
Patient: 49 year old female
Reactions: Erythema Infectiosum, Hepatitis Acute, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Epirubicin
Dosage: 6-cycles
Indication: Intestinal T-Cell Lymphoma
Cyclophosphamide
Dosage: 6 cycles
Indication: Intestinal T-Cell Lymphoma
Vincristine
Dosage: 6-cycles
Indication: Intestinal T-Cell Lymphoma
Rituximab
Indication: Intestinal T-Cell Lymphoma
Dexamethasone
Dosage: 6-cycles
Indication: Intestinal T-Cell Lymphoma
Other drugs received by patient: Lamivudine
Possible Epirubicin side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-07
Patient: male
Reactions: Cytogenetic Abnormality, Anaemia, Refractory Cytopenia With Multilineage Dysplasia, Thrombocytopenia
Drug(s) suspected as cause:
Ibritumomab Tiuxetan
Indication: non-Hodgkin's Lymphoma Stage IV
Vincristine
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Etoposide
Dosage: iev regimen, 3 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-02-01
End date: 2007-05-01
Dexamethasone
Dosage: r-dhap regimen
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2008-03-01
End date: 2008-07-01
Cyclophosphamide
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Prednisone TAB
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Epirubicin
Dosage: iev regimen, 3 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-02-01
End date: 2007-05-01
Etoposide
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Cytarabine
Dosage: r-dhap regimen
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2008-03-01
End date: 2008-07-01
Doxorubicin HCL
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Rituximab
Dosage: r-dhap regimen
Start date: 2008-03-01
End date: 2008-07-01
Prednisolone
Dosage: p-vabec regimen, 8 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
End date: 2009-08-01
Doxorubicin HCL
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Ifosfamide
Dosage: iev regimen, 3 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-02-01
End date: 2007-05-01
Cisplatin
Dosage: r-dhap regimen
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2008-03-01
End date: 2008-07-01
Cyclophosphamide
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Vincristine
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Rituximab
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Bleomycin Sulfate
Dosage: p-vabec regimen, 8 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
End date: 2009-08-01
Possible Epirubicin side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-07
Patient: male
Reactions: Cytogenetic Abnormality, Anaemia, Refractory Cytopenia With Multilineage Dysplasia, Thrombocytopenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: r-dhap regimen
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2008-03-01
End date: 2008-07-01
Ibritumomab Tiuxetan
Indication: non-Hodgkin's Lymphoma Stage IV
Vincristine
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Etoposide
Dosage: iev regimen, 3 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-02-01
End date: 2007-05-01
Cyclophosphamide
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Rituximab
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Bleomycin Sulfate
Dosage: p-vabec regimen, 8 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
End date: 2009-08-01
Doxorubicin HCL
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Epirubicin
Dosage: iev regimen, 3 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-02-01
End date: 2007-05-01
Etoposide
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Prednisolone
Dosage: p-vabec regimen, 8 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
End date: 2009-08-01
Vincristine
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Ifosfamide
Dosage: iev regimen, 3 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-02-01
End date: 2007-05-01
Cytarabine
Dosage: r-dhap regimen
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2008-03-01
End date: 2008-07-01
Cyclophosphamide
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Doxorubicin HCL
Dosage: p-vabec regimen, 8 cycles
End date: 2009-08-01
Prednisone TAB
Dosage: r-chop regimen, 6 cycles
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2005-09-01
End date: 2006-01-01
Rituximab
Dosage: r-dhap regimen
Start date: 2008-03-01
End date: 2008-07-01
Cisplatin
Dosage: r-dhap regimen
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2008-03-01
End date: 2008-07-01
Possible Epirubicin side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-23
Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Carboplatin
Dosage: 400 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Fluorouracil
Dosage: 330 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Etoposide
Dosage: 70 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Epirubicin
Dosage: 27 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Possible Epirubicin side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-01
Patient: 71 year old male
Reactions: Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia
Drug(s) suspected as cause:
Carboplatin
Dosage: 400 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Etoposide
Dosage: 70 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Fluorouracil
Dosage: 330 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Epirubicin
Dosage: 27 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Possible Epirubicin side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-19
Patient: 71 year old male
Reactions: Agranulocytosis, Thrombocytopenia, Decreased Appetite
Drug(s) suspected as cause:
Epirubicin
Carboplatin
Dosage: on day 1
Fluorouracil
Dosage: on days1 1-5
Etoposide
Dosage: on day 1-3
|
